Clinical Trials Browser

Phase 1/2 × Imiquimod × 90 days × Clear all

NCT07210775 2026-03-04

Topical Imiquimod Treatment of Oral Dysplasia

Phase 1/2 Recruiting

DermatologicHead & Neck

Leukoplakia, Leukokeratosis, Hereditary Mucosal